Sure sounds identical, AND, its mentioned on more than just page 27. This is what I've been afraid of and happy about both. Either Regeneron, whom I've said for over a year-plus now, is their toughest and closest competitor, blows ENZC out by getting to market first, OR, they may be one of the best 2 candidates to sign a partnership agreement.
Now praying for the latter, because Regeneron has the top reputation for getting out better treatments in shorter time frames.
We'll see if Charles knows his stuff now for sure, as he had a couple of years lead on Regeneron when his patents on conserved sites and mAB production came in. Hope for the partnership!